诺顿罗氏律师事务所为蒙牛集团以14.3亿澳元（9.83亿美元）收购澳大利亚有机奶粉制造商贝拉米公司全部股份提供了法律意见。安德慎律师事务所则为贝拉米提供了法律意见。

贝拉米2004年创立于澳大利亚塔斯马尼亚岛，目前是世界三大有机奶粉生产商之一，其奶粉是中国市场上有名的“网红产品”。蒙牛首席执行官卢敏放在一份新闻稿中表示，贝拉米领先的产品地位及当地供应链，对蒙牛都具有关键的战略性作用。

根据路透社的报道，中国是贝拉米的重要市场，然而中国政府对于海外代购有着严格控制，这次交易能够使其在等待数年后正式进军中国市场。对蒙牛来说，贝拉米能够满足中国市场对于进口奶粉的追捧——自2008年“毒奶粉”食品安全事件以来，中国消费者仍未对国产奶粉恢复信心。

双方将通过协议安排完成此次交易。协议预计于2019年12月开始执行。

诺顿罗氏律师事务所为此次交易组建了一支跨国团队，由其位于悉尼的公司并购合伙人John Elliott牵头，诺顿罗氏香港公司及并购合伙人Psyche Tai为交易提供了香港市场规范方面的法律咨询，合伙人Peter Haslam提供了融资咨询。

安德慎律师事务所则由合伙人Guy Alexander和Tom Story牵头。

NRF, Allens act on Mengniu’s $983 mln plan to buy infant formula maker Bellamy’s

Norton Rose Fulbright has advised China Mengniu Dairy on its plan to buy infant formula maker Bellamy’s Australia for A$1.43 billion ($983 million), with Allens advising the seller.

According to Reuters, the deal offers Bellamy’s investors a way to cash out of a prospect that has spent years awaiting approval to sell product in its target market, China, while giving Mengniu a prized consumer brand. Foreign formula remains sought after in China following a contamination scandal a decade ago.

The NRF team was led by Sydney-based corporate/M&A partner John Elliott, with Hong Kong partners Psyche Tai and Peter Haslam advising on local regulations and the finance aspects, respectively. The Allens team was led by partners Guy Alexander and Tom Story.

To contact the editorial team, please email ALBEditor@thomsonreuters.com.